These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 27629878

  • 1. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F, Zhu Q, Miao Y, Shen S, Su X, Shi Y.
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts.
    Ge C, Zeng B, Li R, Li Z, Fu Q, Wang W, Wang Z, Dong S, Lai Z, Wang Y, Xue Y, Guo J, Di T, Song X.
    Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.
    Li X, Zhang Q, Fan K, Li B, Li H, Qi H, Guo J, Cao Y, Sun H.
    Int J Mol Sci; 2016 Mar 24; 17(4):437. PubMed ID: 27023518
    [Abstract] [Full Text] [Related]

  • 4. CDK16 overexpressed in non-small cell lung cancer and regulates cancer cell growth and apoptosis via a p27-dependent mechanism.
    Wang H, Liu H, Min S, Shen Y, Li W, Chen Y, Wang X.
    Biomed Pharmacother; 2018 Jul 24; 103():399-405. PubMed ID: 29674275
    [Abstract] [Full Text] [Related]

  • 5. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
    Zhou X, Zhou R, Zhou H, Li Q, Hong J, Meng R, Zhu F, Zhang S, Dai X, Peng G, Wu G, Li Z.
    Cell Physiol Biochem; 2018 Jul 24; 45(5):1827-1839. PubMed ID: 29510376
    [Abstract] [Full Text] [Related]

  • 6. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 7. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D, Luo Y, Gao Y, Yang Y, Wang Y, Xu Y, Tan S, Zhang Y, Duan J, Yang Y.
    Int J Mol Med; 2016 Sep 15; 38(3):927-36. PubMed ID: 27431575
    [Abstract] [Full Text] [Related]

  • 8. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Yue W, Zhao X, Zhang L, Xu S, Liu Z, Ma L, Jia W, Qian Z, Zhang C, Wang Y, Yang X.
    Clin Lung Cancer; 2011 Jan 15; 12(1):43-50. PubMed ID: 21273179
    [Abstract] [Full Text] [Related]

  • 9. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
    Ma J, Wu K, Liu K, Miao R.
    Cancer Biomark; 2018 Jan 15; 22(1):63-72. PubMed ID: 29439314
    [Abstract] [Full Text] [Related]

  • 10. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.
    J Thorac Oncol; 2013 Feb 15; 8(2):161-70. PubMed ID: 23287853
    [Abstract] [Full Text] [Related]

  • 11. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L, Wan C, Chen B, Li M, Liu Y, Ni T, Yang Y, Liu Y, Cong X, Mao G, Xue Q.
    J Cell Biochem; 2014 Jan 15; 115(1):81-92. PubMed ID: 23904219
    [Abstract] [Full Text] [Related]

  • 12. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
    Huang J, Sun C, Wang S, He Q, Li D.
    Mol Biosyst; 2015 Jul 15; 11(7):2051-9. PubMed ID: 25988292
    [Abstract] [Full Text] [Related]

  • 13. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X, Liu X, Zhang Z, Xu L.
    Biochem Biophys Res Commun; 2020 Dec 10; 533(3):354-361. PubMed ID: 32962856
    [Abstract] [Full Text] [Related]

  • 14. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
    Li Z, Huang J, Yuan H, Chen Z, Luo Q, Lu S.
    Oncotarget; 2016 Apr 05; 7(14):18927-39. PubMed ID: 26942878
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N, Liu F, Wu S, Ye M, Ge H, Zhang M, Song Y, Tong L, Zhou J, Bai C.
    BMC Cancer; 2020 Mar 30; 20(1):262. PubMed ID: 32228507
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.